Krisida Cerma

463 total citations
9 papers, 214 citations indexed

About

Krisida Cerma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Krisida Cerma has authored 9 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Krisida Cerma's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Krisida Cerma is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Krisida Cerma collaborates with scholars based in Italy. Krisida Cerma's co-authors include Stefano Cascinu, Fabio Gelsomino, Francesco Catanzariti, Andrea Spallanzani, Kalliopi Andrikou, Andrea Casadei‐Gardini, Massimo Dominici, Claudia Omarini, Luca Moscetti and Federico Piacentini and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and BMC Cancer.

In The Last Decade

Krisida Cerma

7 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krisida Cerma Italy	6	137	74	64	57	47	9	214
D. Páez López-Bravo Spain	5	148 1.1×	77 1.0×	58 0.9×	50 0.9×	39 0.8×	10	204
Valeria Smiroldo Italy	10	199 1.5×	70 0.9×	85 1.3×	41 0.7×	45 1.0×	28	280
Estela Vega Spain	6	116 0.8×	47 0.6×	56 0.9×	34 0.6×	71 1.5×	22	162
Francesca Daniel Italy	7	123 0.9×	29 0.4×	56 0.9×	59 1.0×	68 1.4×	21	180
Enrico Caliman Italy	9	145 1.1×	60 0.8×	81 1.3×	27 0.5×	32 0.7×	24	219
Rosa Rita Silva Italy	8	189 1.4×	66 0.9×	86 1.3×	47 0.8×	51 1.1×	18	253
Federica Villa Italy	7	190 1.4×	47 0.6×	77 1.2×	29 0.5×	81 1.7×	16	225
Xiaohong Yan United States	6	193 1.4×	83 1.1×	84 1.3×	35 0.6×	85 1.8×	7	260
Yasutoshi Kuboki Japan	8	212 1.5×	130 1.8×	74 1.2×	65 1.1×	57 1.2×	26	292
Ana León Spain	9	196 1.4×	72 1.0×	70 1.1×	35 0.6×	101 2.1×	23	260

Countries citing papers authored by Krisida Cerma

Since Specialization

Citations

This map shows the geographic impact of Krisida Cerma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krisida Cerma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krisida Cerma more than expected).

Fields of papers citing papers by Krisida Cerma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krisida Cerma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krisida Cerma. The network helps show where Krisida Cerma may publish in the future.

Co-authorship network of co-authors of Krisida Cerma

This figure shows the co-authorship network connecting the top 25 collaborators of Krisida Cerma. A scholar is included among the top collaborators of Krisida Cerma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krisida Cerma. Krisida Cerma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Cerma, Krisida, Federico Piacentini, Luca Moscetti, et al.. (2023). Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines. 11(1). 109–109. 58 indexed citations

Omarini, Claudia, et al.. (2022). Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist. Clinical Breast Cancer. 22(4). 289–299. 7 indexed citations

Omarini, Claudia, Federico Piacentini, Isabella Sperduti, et al.. (2022). T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. BMC Cancer. 22(1). 623–623. 6 indexed citations

Bergamo, Francesca, Fotios Loupakis, Krisida Cerma, et al.. (2022). Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair–deficient metastatic colorectal cancer: Immunological and molecular profiling. Frontiers in Oncology. 12. 964219–964219. 1 indexed citations

Catanzariti, Francesco, Krisida Cerma, Fabio Gelsomino, et al.. (2020). Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature. Journal of Oncology Pharmacy Practice. 27(3). 766–770. 6 indexed citations

Salati, Massimiliano, Francesco Catanzariti, Krisida Cerma, et al.. (2020). Biliary tract cancer (BTC) in the elderly: A real-world tertiary cancer center experience.. Journal of Clinical Oncology. 38(4_suppl). 492–492.

Salati, Massimiliano, Francesco Catanzariti, Krisida Cerma, et al.. (2019). The impact of gender and immune system determinants on long-term survival in biliary tract cancer. 5(1). 27–30.

Vitale, Maria Giuseppa, Cinzia Baldessari, Michèle Milella, et al.. (2019). Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature. Clinical Genitourinary Cancer. 17(5). e903–e908. 25 indexed citations

Catanzariti, Francesco, Krisida Cerma, Andrea Casadei‐Gardini, et al.. (2019). BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights. International Journal of Molecular Sciences. 20(21). 5369–5369. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact